Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
14 February 2014Website:
http://www.inogen.comNext earnings report:
27 February 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | 6 min agoDividend
Analysts recommendations
Institutional Ownership
INGN Latest News
Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales.
Call Start: 17:00 January 1, 0000 5:26 PM ET Inogen, Inc. (NASDAQ:INGN ) Q3 2024 Earnings Conference Call November 7, 2024, 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and CEO Mike Bourque - Chief Financial Officer Conference Call Participants Rohin Patel - JPMorgan Mike Matson - Needham Operator Welcome to Inogen's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Inogen (INGN) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $1.97 per share a year ago.
INGN shows impressive momentum, driven by strong sales growth, an expanding product portfolio and significant advancements in portable oxygen technology.
Expanding product portfolio and high prospects for POC raise optimism for the INGN stock.
Expanding product portfolio and high prospects for POC raise optimism for the Inogen (INGN) stock.
Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Inogen (INGN) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.42 per share a year ago.
Investing in small-cap stocks can be a gateway to high returns, mainly when these companies exhibit strong growth fundamentals and strategic market positioning. Here, the focus is on three stocks to buy under $10.
What type of business is Inogen?
Inogen, Inc., a company specializing in medical technologies, primarily develops, manufactures, and sells portable oxygen concentrators. Its oxygen concentrators are used to provide supplemental long-term oxygen therapy for patients suffering from chronic respiratory diseases. The company offers the Inogen One, a portable device that concentrates air around the patient to provide them with their sole source of additional oxygen; Inogen At Home - stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents out its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.
What sector is Inogen in?
Inogen is in the Healthcare sector
What industry is Inogen in?
Inogen is in the Medical Devices industry
What country is Inogen from?
Inogen is headquartered in United States
When did Inogen go public?
Inogen initial public offering (IPO) was on 14 February 2014
What is Inogen website?
https://www.inogen.com
Is Inogen in the S&P 500?
No, Inogen is not included in the S&P 500 index
Is Inogen in the NASDAQ 100?
No, Inogen is not included in the NASDAQ 100 index
Is Inogen in the Dow Jones?
No, Inogen is not included in the Dow Jones index
When was Inogen the previous earnings report?
No data
When does Inogen earnings report?
The next expected earnings date for Inogen is 27 February 2025